Web Analytics

3 Latest Announced Rounds

  • $10,500,000
    Unknown

    3 Investors

    HVAC and Refrigeration Equipment Manufacturing
    Nov 5th, 2024
  • $4,000,000
    Series A
    Financial Services
    Nov 5th, 2024
  • $9,500,000
    Seed

    4 Investors

    Software Development
    Nov 5th, 2024
$1,416.01M Raised in 71 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Perpetual Medicines

start up
China - Shanghai
  • 01/12/2023
  • Seed
  • $8,000,000

About Perpetual Medicines

Perpetual Medicines is a fully integrated computational peptide therapeutics company that aims to build the next-generation peptide drug discovery engine. Perpetual Medicines’ platform will combine leading-edge methods in computational physics including MD simulation, FEP, and quantum chemistry with next-generation AI technologies to predict numerous peptide properties with supreme accuracy. We will also couple this “dry” platform with large-scale synthetic laboratory using state-of-the-art biophysical and chemistry methods for high-throughput peptide synthesis & experimentation. Our vision is to disrupt the enormous 40bn-a-year peptide drug market by heralding in a new renaissance in peptide discovery, design & development.


Related People

Kerry BlanchardCo Founder

Kerry Blanchard China - Jing'an District, Shanghai

Drug discovery and development, cell cycle regulation and control, biology of hypoxia, epigenetics, cancer genetics, translational science